Bullous skin disease in lupus erythematosus

Thomas Ijr , Daniel Su WP. Concurrence of lupus erythematosus and dermatitis herpetiformis. A report of Nine cases. Arch Dermatol 1983 ; 119: 740-745.

Moncada B. Dermatitis herpetiformis in association with lupus erythematosus. Arch Dermatol 1974 ; 109: 723-725.

Aronson AJ , Soltani K. , Aronson IK , Ong RT Systemic lupus erythematosus and dermatitis herpetiformis. Arch Dermatol 1979; 115: 68-70.

Clayton CA , Bumham TK Systemic lupus erythematosus and coexisting bullous pemphigoid: Immunofluorescent investigations. J Am Acad Dermatol 1982; 7: 236-245.

Stoll DM , King LE Association of bullous pemphigoid with systemic lupus erythematosus. Arch Dermatol 1984; 120: 362—366.

Szabo E. , Husz S. , Kovacs L. Coexistent atypical bullous pemphigoid and systemic lupus erythematosus. Br J Dermatol 1981; 104: 71-75. 7 Kumar V. et al. Coexistence of bullous pemphigoid and systemic lupus erythematosus. Arch Dermatol 1978; 114: 1187-1190.

Cruz PD , Coldiron BM , Sontheimer RD Concurrent features of cutaneous lupus erythematosus and pemphigus erythematosus following myasthenia gravis and thymoma. J Am Acad Dermatol 1987; 16: 472-479.

Chorzelski T. , Jablonska S. , Blaszczyk M. Immunopathological investigation in the Senear-Usher syndrome (coexistence of pemphigus and lupus erythematosus. Br J Dermatol 1968; 80: 211 217.

Blanchet PH et al. Association of thymoma with pemphigus foliaceous, nephrotic syndrome and lupus biology. Ann Dermatol Venereol 1981 ; 108: 471.

Dotson AD , Raimer SS , Pursley TV , Tschen J. Systemic lupus erythematosus occurring in a patient with epidermolysis bullosa acquisita. Arch Dermatol 1981; 117: 422-426.

Boh E. et al. Epidermolysis bullosa acquisita preceding the development of systemic lupus erythematosus. JAm Acad Dermatol 1990; 22: 587-593.

Yoon J. , Moon TK , Lee KH , Kim SC Fatal vascular involvement in systemic lupus erythematosus following epidermolysis bullosa acquisita. Acta Derm Venereol 1995 ; 75: 143-146.

Davies MG , Marks R. Simultaneous systemic lupus erythematosus and dermatitis herpetiformis. Arch Dermatol 1976; 112: 1292-1294.

Lau M. , Kaufmann-Grunzinger I. , Raghunath MA Case report of a patient with features of systemic lupus erythematosus and linear IgA diseases. Br J Dermatol 1991; 124: 498-502.

Archibald GC Epidermolysis bullosa dystrophica and systemic lupus erythematosus. Proc R Soc Med 1976; 69: 881-883.

Rowell NR , Beck JS , Anderson JR Lupus erythematosus and erythema multiforme-like lesions. Arch Dermatol 1963; 88: 176-180.

Gammon WR , Briggaman RA Bullous eruption of systemic lupus erythematosus. In: Wojnarowska F , Briggaman RA (eds). Management of Blistering Diseases Chapman and Hall Ltd: London, 1990, pp 263-275.

Tan EM et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.

Barton DD , Fine J. , Gammon WR , Sams Jr WM. Bullous systemic lupus erythematosus: An unusual clinical course and detectable circulating autoantibodies to the epidermolysis bullosa antigen . J Am Acad Dermatol 1986; 15: 369-373.

Gammon WR , Woodley DT , Dole KC , Briggaman RA Evidence that anti-basement membrane zone antibodies in bullous eruption of systemic lupus erythematosus recognise epidermolysis bullosa acquisita autoantigen . J Invest Dermatol 1985; 84: 472-476.

Gammon WR , Briggaman RA Bullous Sle : A phenotypically distinctive but immunologically heterogenous bullous disorder . J Invest Dermatol 1993; 100: 28S-24S.

Gammon WR , Inman Iao , Wheeler Jce. Differences in complement-dependent chemotactic activity generated by bullous pemphigoid and epidermolysis bullosa acquisita immune complexes: demonstration by leukocyte attachment and organ culture methods. J Invest Dermatol 1984; 83: 57-61.

Gammon WR et al. Generation of C5-dependent bioactivity of tissue-bound anti-BMZ autoantibodies. J Invest Dermatol 1989; 93: 195-200.

Hendrix JD , Jeffes Ewb , Briggaman RA , Gammon WR Monoclonal antibodies to type VII collagen induce basement membrane inflammation in vivo that is synergistically enhanced by exogenous and endogenous cytokines . Clin Res 1989; 37: 351a.

Yell JA et al. Bullous systemic lupus erythematosus: revised criteria for diagnosis . Br J Dermatol 1995 ; 132: 921-928.

Venning VA et al. The clinical expression of bullous pemphigoid is not determined by the specificity of the target antigen. Br J Dermatol 1991; 125: 561-565.

Olansky AJ et al. Bullous systemic lupus erythematosus. J Am Acad Dermatol 1982; 7: 511-520.

Lever. Connective Tissue Diseases. In: Lever WF , Schaumberg-Lever G (eds). Histopathology of the Skin 6th edn, J.B. Lippincott Company: Philadelphia, 1983, pp 448-455.

Bernard P. et al. Incidence and distribution of subepidermal autoimmune bullous skin diseases in three french regions. Arch Dermatol 1995; 131: 48-52.

Pedro SD , Dahl MV Direct immunofluorescence of bullous systemic lupus erythematosus. Arch Dermatol 1973 ; 107: 118-120.

Burge S. , Schomberg K. , Wojnarowska F. Bullous eruption of SLE—a case report and investigation of the relationship of anti-basement-membrane-zone antibodies to blistering. Clin Exp Dermatol 1991; 16: 133-138.

McHenry PM , Dagg JH , Tidman MJ , Lever RS Epidermolysis bullosa acquisita occurring in association with systemic lupus erythematosus. Clin Exp Dermatol 1993 ; 18: 378-380.

Burrows NP et al. Bullous eruption of systemic lupus erythematosus: a clinicopathological study of four cases. Br J Dermatol 1993; 128: 332-338.

Yell JA , Wojnarowska F. , Allen J. , Burge SM Bullous systemic lupus erythematosus- variable disease. Lupus 1993; 2: 383-385.

Shirahama S. , Yagi H. , Furukawa F. , Takigawa M. A case of bullous systemic lupus erythematosus . Dermatology 1994; 189: 95—96.

Jacoby RA , Abraham AA Bullous dermatosis and systemic lupus erythematosus in a 15-year old boy. Arch Dermatol 1979 ; 115: 1094-1097.

Penneys NS , Wiley HE Herpetiform blisters in systemic lupus erythematosus. Arch Dermatol 1979 ; 115: 1427-1428.

Hall RP , Lawley TJ , Smith HR , Katz SI Bullous eruption of systemic lupus erythematosus. Ann Int Med 1982; 97: 165-170.

Camisa C. , Sharma HM Vesicobullous systemic lupus erythematosus. J Am Acad Dermatol 1983; 9: 924-933.

Gammon WR et al. Evidence supporting a role of immune complex-mediated inflammation in the pathogenesis of bullous lesions of systemic lupus erythematosus. J Invest Dermatol 1983; 81: 320-325.

Tani M. et al. Systemic lupus erythematosus with vesicobullous lesions. Arch Dermatol 1984; 120: 1497-1501.

Camisa C. Vesicobullous systemic lupus erythematosus. A report of four cases. J Am Acad Dermatol 1988 ; 18: 93-99.

Rappersberger K. , Tschachler MT , Wolff K. Bullous disease in systemic lupus erythematosus . J Am Acad Dermatol 1989; 21: 745-752.

Kirtschig G. et al. Acquired bullous diseases of childhood: re-evaluation of diagnosis by indirect immunofluorescence examination of IM NaCl split skin and immunoblotting. Br J Dermatol 1994; 130: 610-616.

Morrison LH , Diaz LA , Anhalt GJ Bullous pemphigoid. In: Wojnarowska F , Briggaman RA (eds). Management of Blistering Diseases. Chapman and Hall Medical: London, 1990, pp 63-82.

Venning VA et al. Mucosal involvement in bullous and cicatricial pemphigoid. A clinical and immunopathological study. Br J Dermatol 1988; 118: 7-15.

Kirtschig G. , Wojnarowska F. Autoimmune blistering diseases: an update of diagnostic methods and investigations. Clin Exp Dermatol 1994; 19: 97-112.

Yaoita H. et al. Epidermolysis bullosa acquisita: ultrastructural and immunological studies. J Invest Dermatol 1981; 76: 288-292.

Gammon WR et al. Increased frequency of HLA-DR2 in patients with autoantibodies to epidermolysis bullosa acquisita antigen: evidence that the expression of autoimmunity to type VII collagen is HLA class II allele associated. J Invest Dermatol 1988 ; 91: 228-232.

Gammon WR et al. Epidermolysis bullosa acquisita-a pemphigoid-like disease. J Amer Acad Dermatol 1984; 11: 820,832.

Wojnarowska F. , Marsden RA , Bhogal B. , Black MM Chronic bullous disease of childhood, childhood cicatricial pemphigoid and linear IgA disease of adults, a comparative study demonstrating clinical and immunopathological overlap. J Am Acad Dermatol 1988; 19: 792-805.

Fry L. Dermatitis Herpetiformis. In: Wojnarowska F , Briggaman RA (eds). Management of Blistering Diseases. Chapman and Hall Medical : London, 1990, pp 139-160.

Fry L. et al. Small intestinal structure and function, and haematological changes in dermatitis herpetiformis. Lancet 1967; ii: 729-734.

Chorzelski TP , Jablonska S. , Beutner EH Relationship of autoimmunity to clinical findings in pemphigus. In: Beutner EH , Chorzelski TP , Kumar V (eds). Immunopathology of the Skin. John Wiley and Sons: New York, 1987, pp 249-268.

Diaz LA , Sampia Sap , Rivitti EA Endemic pemphigus foliaceus (Fogo Selvaem): II Current and historic epidemiologic studies. J Invest Dermatol 1989; 92: 4-12.

Kirtschig G. , Marinkovich P. , Burgeson RE , Yancey KB Anti-Basement membrane autoantibodies in patients with anti-epiligrin cicatricial pemphigoid bind the α subunit of Laminin 5. J Invest Dermatol 1995; 105(4): 543—548.

Millard LG , Rowell NR , Rajah SM Histocompatibility antigens in discoid and systemic lupus erythematosus. Br J Dermatol 1977; 96: 139-144.

Walport MJ , Black CM , Batchelor JR The immunogenetics of SLE. Clin Rheum Dis 1982; 8: 3-21.

Goldberg MA et al. Histocompatibility antigens in systemic lupus erythematosus. Arthritis Rheum 1976; 19: 129-132.

Kachru Rajb et al. A significant increase of HLA-DR3 and DR2 in systemic lupus erythematosus among Blacks. J Rheumatol 1984 ; 11: 471-474.

Harley JB et al. A model for disease heterogeneity in systemic lupus erythematosus . Arthritis Rheum 1989; 32: 826-836.

Jones JV et al. Familial systemic lupus erythematosus: evidence for separate loci controlling C4 deficiency and formation of antibodies to DNA, nRNP, Ro and La. J Rheumatol 1987; 14: 263-267.

Collier PM , Wojnarowska F. MHC class I and II antigens in linear IgA dermatosis. J Invest Derinatol 1992; 98: 526 (Abstract).

Hall MA et al. HLA association with dermatitis herpetiformis is accounted for by a cis or trans associated DQ heterodimer. Gut 1991; 32: 487-490.

Gammon WR et al. Functional evidence for complement activating immune complexes in the skin of patients with bullous pemphigoid. J Invest Dermatol 1982 ; 78: 52-57.

Jones DA et al. Immunodominant autoepitopes of type VII collagen are short, paired peptide sequences within the fibronectin type III homology region of the noncollagenous (NC1) domain. J Invest Dermatol 1995; 104: 231 235.